As part of its advocacy program in the United States, ACRO submits regulatory comments to US regulators. This comment letter, submitted by ACRO to NIH in 2023 about NCATS RFI: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials can be found below.